Camden Capital »

ResMed shares owned by Camden Capital

Quarter-by-quarter ownership of ResMed (RMD) shares owned by Camden Capital from 13F filings

Historical chart of Camden Capital investment in ResMed

Tip: Access up to 7 years of quarterly data

All positions including ResMed held by Camden Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in ResMed by Camden Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.6M 6.7k 240.91
2025-09-30 $279k 1.0k 273.71
2025-06-30 $204k 792 257.92

More positions owned by Camden Capital

Onemain Holdings (OMF)
Citigroup Com New (C)
Micron Technology (MU)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ge Aerospace Com New (GE)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Ishares Tr Core S&p500 Etf (IVV)
Morgan Stanley Com New (MS)
Wells Fargo & Company (WFC)
Bank of America Corporation (BAC)
Microsoft Corporation (MSFT)
Flagstar Bank National Assoc Com New (FLG)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for Camden Capital

Top funds holding ResMed

Vanguard Group
BlackRock
State Street Corporation
Bank of New York Mellon
Geode Capital Management
Invesco
Northern Trust
First Trust Advisors
Deutsche Bank Aktiengesellschaft
Charles Schwab Investment Management
Swedbank AB
Nordea Investment Management Ab
Norges Bank Investment Management
Legal & General Group
Dimensional Fund Advisors

View all funds holding ResMed